Société Longboard Pharmaceuticals, Inc.
Actions
LBPH
US54300N1037
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
20,62 USD | +4,56% | +10,31% | +241,54% |
12/03 | Longboard Pharmaceuticals, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023 | CI |
16/01 | LONGBOARD PHARMACEUTICALS, INC. : Cantor Fitzgerald reste à l'achat | ZM |
Métier
Nombre d'employés: 50
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 01/01/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Dewey McLin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Randall Kaye
CTO | Chief Tech/Sci/R&D Officer | 62 | 21/03/22 |
Julie Baker
PRN | Corporate Officer/Principal | - | 01/01/23 |
Gus Cardenas
PRN | Corporate Officer/Principal | - | - |
Anne Danks
PRN | Corporate Officer/Principal | - | - |
Marco Peters
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 01/12/20 |
Director/Board Member | 68 | 01/12/20 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 01/02/20 |
Casey Lynch
BRD | Director/Board Member | 50 | 01/02/21 |
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Corinne Le Goff
BRD | Director/Board Member | 58 | 01/03/21 |
Jane Tiller
BRD | Director/Board Member | 59 | 15/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 2 420 755 | 0 | 0 | 92,26 % |
Action B | 1 | 33 607 490 | 33 241 120 ( 98,91 %) | 0 |
Coordonnées société
Longboard Pharmaceuticals, Inc.
4275 Executive Square Suite 950
92037, La Jolla
+
http://www.longboardpharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+241,54% | 767 M | |
-2,58% | 103 Md | |
+1,50% | 95,28 Md | |
+1,46% | 22,15 Md | |
-15,73% | 21,02 Md | |
-8,58% | 18,15 Md | |
-38,74% | 16,73 Md | |
-13,21% | 16,05 Md | |
+5,18% | 13,68 Md | |
+33,45% | 12,17 Md |
- Bourse
- Actions
- Action LBPH
- Société Longboard Pharmaceuticals, Inc.